Literature DB >> 11591713

Dual role of p300 in the regulation of p53 stability.

H Kawai1, L Nie, D Wiederschain, Z M Yuan.   

Abstract

While the function of p300 as a transcriptional co-activator of p53 is well documented, its role in the regulation of p53 stability remains ill-defined since opposite effects of p300 on p53 levels have been reported. We show here that p300 stabilizes both p53 and its negative regulator MDM2, thereby enhancing the p53/MDM2 negative regulatory loop. Binding of p300 is associated with the retention of p53 in the nucleus, which results in the accumulation of p53 in an acetylase-independent manner. Stabilization of MDM2, on the other hand, requires the acetylase activity of p300. Importantly, MDM2, once expressed, is able to reverse the stabilizing effect of p300 on p53. A temperature-permissive p53-expressing cell line enabled us to demonstrate the completely opposite roles of p300 in the regulation of p53 stability, depending on the expression of MDM2. Prior to p53 activation, when MDM2 levels are low, p300 acts as a positive regulator to increase p53 levels. Upon shifting to permissive temperature, however, when MDM2 expression is induced, p300 becomes a negative regulator of p53 by stabilizing MDM2 and thereby augmenting MDM2's ability to target p53 for degradation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11591713     DOI: 10.1074/jbc.M107770200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  Coactivator-dependent acetylation stabilizes members of the SREBP family of transcription factors.

Authors:  Valeria Giandomenico; Maria Simonsson; Eva Grönroos; Johan Ericsson
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

2.  HIV-1 viral infectivity factor interacts with TP53 to induce G2 cell cycle arrest and positively regulate viral replication.

Authors:  Taisuke Izumi; Katsuhiro Io; Masashi Matsui; Kotaro Shirakawa; Masanobu Shinohara; Yuya Nagai; Masahiro Kawahara; Masayuki Kobayashi; Hiroshi Kondoh; Naoko Misawa; Yoshio Koyanagi; Takashi Uchiyama; Akifumi Takaori-Kondo
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-11       Impact factor: 11.205

3.  Epigenetic mechanisms of Rubinstein-Taybi syndrome.

Authors:  Elizabeth Park; Yunha Kim; Hyun Ryu; Neil W Kowall; Junghee Lee; Hoon Ryu
Journal:  Neuromolecular Med       Date:  2014-01-01       Impact factor: 3.843

4.  p53 C-terminal phosphorylation by CHK1 and CHK2 participates in the regulation of DNA-damage-induced C-terminal acetylation.

Authors:  Yi-Hung Ou; Pei-Han Chung; Te-Ping Sun; Sheau-Yann Shieh
Journal:  Mol Biol Cell       Date:  2005-01-19       Impact factor: 4.138

5.  Runt-related transcription factor 1 (RUNX1) stimulates tumor suppressor p53 protein in response to DNA damage through complex formation and acetylation.

Authors:  Dan Wu; Toshinori Ozaki; Yukari Yoshihara; Natsumi Kubo; Akira Nakagawara
Journal:  J Biol Chem       Date:  2012-11-12       Impact factor: 5.157

6.  Regulation of ERK1 gene expression by coactivator proteins.

Authors:  Beanca Y Chu; Kim Tran; Tony K S Ku; David L Crowe
Journal:  Biochem J       Date:  2005-12-15       Impact factor: 3.857

7.  Trichostatin A enhances acetylation as well as protein stability of ERalpha through induction of p300 protein.

Authors:  Sung-Hye Kim; Hyun-Jin Kang; Hyelin Na; Mi-Ock Lee
Journal:  Breast Cancer Res       Date:  2010-04-13       Impact factor: 6.466

8.  Human papillomavirus oncoprotein E6 inactivates the transcriptional coactivator human ADA3.

Authors:  Ajay Kumar; Yongtong Zhao; Gaoyuan Meng; Musheng Zeng; Seetha Srinivasan; Laurie M Delmolino; Qingshen Gao; Goberdhan Dimri; Georg F Weber; David E Wazer; Hamid Band; Vimla Band
Journal:  Mol Cell Biol       Date:  2002-08       Impact factor: 4.272

9.  p300 expression repression by hypermethylation associated with tumour invasion and metastasis in oesophageal squamous cell carcinoma.

Authors:  Changsong Zhang; Ke Li; Lixin Wei; Zhengyou Li; Ping Yu; Lijuan Teng; Kusheng Wu; Jin Zhu
Journal:  J Clin Pathol       Date:  2007-11       Impact factor: 3.411

Review 10.  p53: the attractive tumor suppressor in the cancer research field.

Authors:  Toshinori Ozaki; Akira Nakagawara
Journal:  J Biomed Biotechnol       Date:  2010-12-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.